ODI Pharma AB (publ) (NGM: ODI)

ODI Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 27, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	56	110	84	82	68	85
Market Cap Growth	-3.95%	30.91%	1.85%	21.08%	-20.36%	-
Enterprise Value	51	104	80	73	52	63
Last Close Price	3.68	7.20	5.50	5.40	4.46	5.60
PS Ratio	2.54	4.92	600.26	262.63	-	-
PB Ratio	106.27	54.76	32.54	8.87	4.16	4.25
P/TBV Ratio	126.48	54.76	32.54	8.87	4.16	4.25
EV/Sales Ratio	2.31	4.65	573.75	233.92	-	-
EV/EBITDA Ratio	45.99	240.49	-	-	-	-
EV/EBIT Ratio	46.10	242.14	-	-	-	-
Asset Turnover	3.43	2.18	0.01	0.02	-	-
Inventory Turnover	-	-	0.77	0.34	-	-
Quick Ratio	1.02	1.14	1.30	6.84	26.74	26.33
Current Ratio	1.09	1.20	1.46	8.49	29.00	26.53
Return on Equity (ROE)	42.01%	-24.84%	-116.63%	-56.64%	-21.89%	-41.15%
Return on Assets (ROA)	10.75%	2.62%	-45.57%	-32.91%	-13.13%	-24.35%
Return on Capital (ROIC)	87.97%	11.70%	-71.95%	-35.25%	-13.62%	-25.57%
Earnings Yield	0.59%	-0.52%	-8.24%	-8.81%	-5.87%	-5.82%
FCF Yield	-0.34%	-3.49%	-6.10%	-8.98%	-8.93%	-5.60%
Buyback Yield / Dilution	0.76%	0.76%	-1.69%	1.52%	-11.10%	-10.04%
Total Shareholder Return	0.76%	0.76%	-1.69%	1.52%	-11.10%	-10.04%

Source: S&P Capital IQ. Standard template. Financial Sources.